Health Care: Health Services

TearLab Corp (TEAR: NASDAQ)

$1.58 n/a | n/a%
11/27/15 - 12:58 PM ET
Company Profile
Price and Volume
Recent Price 1.58
52 Week High 3.15
52 Week Low 1.50
Avg. Daily Vol. (Mil) 0.10
Beta (3 year) 3.43
Share Related Items
Mkt Cap (Mil) 53.34
Shares Out (Mil) 33.76
Float (Mil) 30.19
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.70
Current Ratio 2.40
LT Debt/ Equity 4.29
Total Debt / Equity 4.29
Valuation Ratios
Price Earnings n.a.
Price/Sales 2.25
Price/Book 15.25
Price/Cash Flow -1.90
Per Share Data
Earnings -0.93
Sales 0.70
Book Value 0.10
Cash Flow -0.82
Business Summary
TearLab Corp is an in-vitro diagnostic company. The Company commercialized a proprietary tear testing platform, the TearLab Osmolarity System that enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film.
General Information
9980Huennekens Street
San Diego, CA 92121
Industry : Health Services
Sector: Health Care
Employees: 132
CEO: Elias Vamvakas
Short Interest
Current Month (Mil) 3.26
Previous Month (Mil) 3.24
Short Interest Ratio (Days) 46.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -119.10
Return on Investments -169.00
Gross Margin 57.30
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with TEAR

Latest TEAR Headlines from TheStreet

More Financial News for TEAR

Press Releases for TEAR

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter